Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol–cyproterone acetate

Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-reactive Protein and Homocysteine in Young Women

(2010) Sabina Cauci et al.   OBSTETRICS AND GYNECOLOGY

Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study

(2009) Fulvia Mancini et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study

(2009) Cesare Battaglia et al.   FERTILITY AND STERILITY

The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome

(2009) E. Diamanti-Kandarakis et al.   Obesity Reviews

ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome

(2009)   OBSTETRICS AND GYNECOLOGY

Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis

(2009) Winifred Mak et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?

(2008) Gustavo Mafaldo Soares et al.   CLINICAL ENDOCRINOLOGY

Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women

(2008) Patrícia Margareth Lizarelli et al.   CONTRACEPTION

Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study

(2008) Fulvia Mancini et al.   FERTILITY AND STERILITY

Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome

(2008) Manuel Luque-Ramírez et al.   FERTILITY AND STERILITY

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

(2008) G. M. Soares et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials

(2008) Kathleen Hoeger et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Body weight and oral contraceptives are the most important modulators of serum CRP levels

(2008) S. Buchbinder et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment

(2008) Bulent Yildiz   SEMINARS IN REPRODUCTIVE MEDICINE